3 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow acipimox: new trials by email Literature Review of acipimox trials Research Report on acipimox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes acipimox, Placebo Oral Capsule - Type 2 Diabetes | Phase 2 / Phase 3 | Completed | Medical University of Vienna | 8 | 2013-10-01 | 2017-04-04 |
| Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes Acipimox, Placebo - Type 1 Diabetes | Phase 3 | Completed | University of Colorado, Denver | 28 | 2011-06-01 | 2022-01-21 |
| The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome acipimox, Placebo - Metabolic Syndrome | Phase 2 / Phase 3 | Completed | Brigham and Women's Hospital | 40 | 2006-04-01 | 2023-02-21 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Insulin Resistance (1) · Metabolic Syndrome (1)
Brigham and Women's Hospital (1) · Medical University of Vienna (1) · University of Colorado, Denver (1)
United States (2) · Austria (1)
Irene Schauer, MD, PhD (1) · Joshua A. Beckman, M.D. (1) · Michael Krebs, Prof.MD (1)